Cell Therapeutics Cuts 36 Employees
Summary
Cell Therapeutics Cuts 36 Employees Xconomy Seattle — Cell Therapeutics (NASDAQ: CTIC), the Seattle-based biotech company, said it has cut 36 jobs to conserve cash.The move comes less than a week after the company’s application to sell a new drug for non-Hodgkin’s lymphoma was rejected by the FDA.The company says it now expects to spend about $60 million on operations this year, down 21 percent from its previous forecast.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected